148 related articles for article (PubMed ID: 21378006)
1. Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas.
Gaitanis G; Kalogeropoulos C; Bassukas ID
Br J Ophthalmol; 2011 Jun; 95(6):890-2. PubMed ID: 21378006
[No Abstract] [Full Text] [Related]
2. Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application.
Gaitanis G; Nomikos K; Vava E; Alexopoulos EC; Bassukas ID
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1427-31. PubMed ID: 19555364
[TBL] [Abstract][Full Text] [Related]
3. Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative.
Gaitanis G; Kalogeropoulos CD; Bassukas ID
Dermatology; 2016; 232(1):17-21. PubMed ID: 26583773
[TBL] [Abstract][Full Text] [Related]
4. Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Gaitanis G; Bassukas ID
Acta Derm Venereol; 2014 Jan; 94(1):38-44. PubMed ID: 23722308
[TBL] [Abstract][Full Text] [Related]
5. [Periocular basal cell carcinoma treatment tendencies].
García Martín E; Fernández Tirado FJ
Arch Soc Esp Oftalmol; 2010 Aug; 85(8):261-2. PubMed ID: 21130940
[No Abstract] [Full Text] [Related]
6. Imiquimod in the treatment of eyelid basal cell carcinoma.
Leppälä J; Kaarniranta K; Uusitalo H; Kontkanen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):566-8. PubMed ID: 17376190
[TBL] [Abstract][Full Text] [Related]
7. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
8. Ulcerated nodular nasal basal cell carcinoma successfully treated with imiquimod 5% cream.
Cantisani C; Richetta AG; Balsamo G; Mattozzi C; Melis L; Frati R; Calvieri S
J Drugs Dermatol; 2011 Mar; 10(3):240-1. PubMed ID: 21369638
[No Abstract] [Full Text] [Related]
9. Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label study.
Gaitanis G; Alexopoulos EC; Bassukas ID
Eur J Dermatol; 2011; 21(6):952-8. PubMed ID: 21926038
[TBL] [Abstract][Full Text] [Related]
10. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication.
Costales-Álvarez C; Álvarez-Coronado M; Rozas-Reyes P; González-Rodríguez CM; Fernández-Vega L
Arch Soc Esp Oftalmol; 2017 Feb; 92(2):93-96. PubMed ID: 27601079
[TBL] [Abstract][Full Text] [Related]
12. Cryosurgery of skin cancer--in proper perspective.
Zacarian SA
J Dermatol Surg; 1975 Oct; 1(3):33-8. PubMed ID: 1223162
[No Abstract] [Full Text] [Related]
13. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
Oster-Schmidt C; Altmeyer P; Stücker M
Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
[No Abstract] [Full Text] [Related]
14. Cryosurgery for basal-cell carcinomas on the wings of the nose and in the nasolabial folds.
Kuflik EG
J Dermatol Surg Oncol; 1981 Jan; 7(1):23-5. PubMed ID: 7204727
[No Abstract] [Full Text] [Related]
15. Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
Nakuçi M; Bassukas ID
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):35-8. PubMed ID: 23836356
[TBL] [Abstract][Full Text] [Related]
16. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Moehrle M; Breuninger H; Schippert W; Häfner HM
Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
[No Abstract] [Full Text] [Related]
17. What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream.
Sukal SA; Mahlberg MJ; Brightman L; Daniel DR; Mintzis MM; Geronemus RG
Dermatol Surg; 2009 Nov; 35(11):1831-4. PubMed ID: 19691665
[No Abstract] [Full Text] [Related]
18. Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid.
Apalla Z; Karteridou A; Lallas A; Tzellos T; Lefaki I; Sotiriou E; Varytimiadis D
Dermatol Surg; 2013 Jan; 39(1 Pt 1):146-7. PubMed ID: 23301789
[No Abstract] [Full Text] [Related]
19. Eyelid and periorbital skin basal cell carcinoma: oculoplastic management and surgery.
Mannor GE; Chern PL; Barnette D
Int Ophthalmol Clin; 2009; 49(4):1-16. PubMed ID: 20348854
[No Abstract] [Full Text] [Related]
20. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
